Wang Shaomeng

Wang Shaomeng is a declared insider of Ascentage Pharma Group International, with filings sourced from SEC (Form 4). We count 18 filings; the first trade dates from 8 February 2021 and the latest from 19 May 2023.

On the open market, the record shows 7 purchases worth €189.3M and 11 sales worth €193.2M. The totals do not cover 7 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2023 alone, the filings show 2 purchases and 1 sale.

Half of the purchases are above €21k and half below. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 29 September 2023: an open-market purchase, in Ascentage Pharma Group International. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.